Docket
117th Congress · SENATE BILLBILL

S. 4302 — Biologics Market Transparency Act of 2022

“A bill to amend the Federal Food, Drug, and Cosmetic Act to require prompt reports of marketing status by holders of approved applications for biological products, and for other purposes.”

Health
Introduced May 25, 2022
Last action May 25, 2022
Pipeline · Bill → Law
Step 1
Introduced
May 25, 2022
Step 2
Referred
May 25, 2022
HELP
Step 3
Committee
Step 4
Senate
Step 5
House floor
Step 6
Resolve Changes
Step 7
Signed
SummaryNo summary available

No CRS summary available for this bill.

Provisions · 2 sectionsIntroduced in Senate
Timeline · 2 actions
May 25, 2022
Introduced in Senate
May 25, 2022
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.